Overview

Single Dose Pharmacokinetics of Egalet® Oxycodone

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet® oxycodone formulations and compare to a marketed oxycodone product.

Phase:

Phase 1

Details

Lead Sponsor:

Egalet Ltd

Treatments:

Oxycodone